MedCity News December 18, 2024
Rob DiCicco

Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; it’s always about people, processes, and technology.

Since 2011, when Watson won Jeopardy, there has been a growing crescendo of the promise of data, analytics, and AI. While it is impossible to watch a sporting event without a major tech company informing us how AI is improving performance athlete’s safety and how to beat the house with a betting app, the question that Pharma needs to answer is: what is hope and what is hype when it comes to improving patient outcomes and R&D productivity?

To better understand the challenge, one...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Meta’s new BLT architecture replaces tokens to make LLMs more efficient and versatile
Johns Hopkins Medicine inks AI deal with Abridge
Congress' AI report leaves some tech-watchers on edge
Only 20% of AI devices for children used pediatric data to train: 3 notes
Top Decentralized AI Projects Of 2025 Amid OpenAI Copyright Concerns

Share This Article